Published in Ther Drug Monit on August 01, 2002
Drug interactions in childhood cancer. Lancet Oncol (2010) 0.83
Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma. Br J Clin Pharmacol (2010) 0.80
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams. Pharmaceutics (2011) 0.76
Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet (2017) 0.75
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol (2010) 4.21
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood (2006) 3.00
Guidelines for submitting adverse event reports for publication. Drug Saf (2007) 2.38
Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med (2012) 2.16
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood (2008) 2.15
The effects of coffee and napping on nighttime highway driving: a randomized trial. Ann Intern Med (2006) 2.04
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf (2009) 1.96
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol (2009) 1.72
Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood (2011) 1.63
The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD. Pulm Pharmacol Ther (2010) 1.63
Fatigue, sleep restriction and driving performance. Accid Anal Prev (2005) 1.60
Differences between clinical trials and postmarketing use. Br J Clin Pharmacol (2004) 1.54
Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine. Evid Based Complement Alternat Med (2011) 1.51
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol (2005) 1.48
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol (2006) 1.47
Rates of spontaneous reporting of adverse drug reactions in France. JAMA (2002) 1.45
Fluvastatin reduces cardiac mortality in patients with coronary heart disease. Cardiovasc Drugs Ther (2004) 1.40
Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging (2008) 1.39
Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol (2004) 1.39
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf (2007) 1.37
Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol (2005) 1.33
Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. Therapie (2004) 1.28
Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. Fundam Clin Pharmacol (2005) 1.27
Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage. Fundam Clin Pharmacol (2004) 1.24
Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf (2007) 1.23
Endoscopic endonasal minimal access approach to the clivus: case series and technical nuances. Neurosurgery (2010) 1.20
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf (2009) 1.20
Endoscopic endonasal transclival resection of chordomas: operative technique, clinical outcome, and review of the literature. J Neurosurg (2010) 1.18
Age, performance and sleep deprivation. J Sleep Res (2004) 1.17
Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol (2002) 1.15
The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder. BMC Psychiatry (2009) 1.14
Fatigue, sleepiness, and performance in simulated versus real driving conditions. Sleep (2005) 1.14
Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices. Clin Lab (2003) 1.12
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol (2007) 1.10
Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Ther Drug Monit (2005) 1.10
The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf (2009) 1.10
Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS. Clin Chim Acta (2011) 1.07
Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis. Evid Based Complement Alternat Med (2011) 1.04
Aging and nocturnal driving: better with coffee or a nap? A randomized study. Sleep (2007) 1.00
High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Ther Drug Monit (2003) 0.99
Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment. Sleep (2003) 0.99
Underdiagnosis of nocturnal symptoms in asthma in general practice. J Asthma (2006) 0.99
Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. J Pharm Biomed Anal (2006) 0.98
Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis. Evid Based Complement Alternat Med (2011) 0.98
Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS. Clin Chim Acta (2009) 0.97
Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol (2004) 0.97
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol (2004) 0.97
Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice. BMC Complement Altern Med (2012) 0.96
Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France. Fundam Clin Pharmacol (2009) 0.96
Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb Res (2003) 0.95
Antihypertensive effects of Ocimum basilicum L. (OBL) on blood pressure in renovascular hypertensive rats. Hypertens Res (2010) 0.95
Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology (2003) 0.95
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug Saf (2005) 0.95
Sleepiness, near-misses and driving accidents among a representative population of French drivers. J Sleep Res (2010) 0.95
The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol (2008) 0.95
Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea. Sleep (2007) 0.95
Improving pharmacovigilance in Europe. BMJ (2010) 0.94
The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model. Pharmacogn Mag (2012) 0.94
Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta Ophthalmol (2012) 0.94
Risk of injurious road traffic crash after prescription of antidepressants. J Clin Psychiatry (2012) 0.93
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing (2008) 0.93
[Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]. Zhongguo Zhong Yao Za Zhi (2007) 0.93
Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf (2012) 0.93
Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthma. Evid Based Complement Alternat Med (2010) 0.93
A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf (2010) 0.92
Effectiveness of Fluticasone Furoate-Vilanterol in COPD. N Engl J Med (2016) 0.92
Sleep duration and caffeine consumption in a French middle-aged working population. Sleep Med (2005) 0.92
Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol (2010) 0.91
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res (2002) 0.91
A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol (2006) 0.91
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord (2011) 0.91
Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res Ther (2009) 0.90
Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther (2008) 0.90
Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Drug Saf (2013) 0.90
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol (2012) 0.89
Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea. Clin Gastroenterol Hepatol (2008) 0.89
Drug interactions between inhaled corticosteroids and enzymatic inhibitors. Eur J Clin Pharmacol (2009) 0.89
Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet. J Ethnopharmacol (2012) 0.89
[Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues]. Drugs (2003) 0.88
Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf (2013) 0.88
Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study. J Neurol (2011) 0.88
Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma. Chest (2013) 0.88
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France. Drug Saf (2012) 0.87
The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf (2005) 0.87
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med (2007) 0.87
Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf (2010) 0.87